tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Mccarthy, 348 are a BUY (85.29%), 60 are a HOLD (14.71%).
Analyst Jason Mccarthy, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 43.04% that have a potential upside of 58.33% achieved within 346 days.
Jason Mccarthy’s has documented 734 price targets and ratings displayed on 113 stocks. The coverage is on Healthcare, Consumer Defensive, Technology, Energy, Consumer Cyclical, Financial Services sectors.
Most recent stock forecast was given on FEMY, Femasys at 14-Aug-2026.
Analyst best performing recommendations are on ONTX (ONCONOVA THERAPEUTICS).
The best stock recommendation documented was for ANVS (ANNOVIS BIO) at 5/13/2021. The price target of $45 was fulfilled within 8 days with a profit of $21.72 (93.3%) receiving and performance score of 116.62.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Nov-2022
$30
$25.57 (577.20%)
$28
1 months 4 days ago
(18-Sep-2026)
1/6 (16.67%)
$24.43 (438.60%)
1
Buy Since 17-Mar-2026
$21
$16.57 (374.04%)
$22
2 months 8 days ago
(14-Aug-2026)
0/2 (0%)
$15.01 (250.58%)
Buy Since 16-Oct-2017
$20
$14.39 (256.51%)
$20
4 months 24 days ago
(28-May-2026)
0/13 (0%)
$14.22 (246.02%)
Buy Since 29-Apr-2025
$17
$12.57 (283.75%)
$19
7 months 5 days ago
(17-Mar-2026)
0/4 (0%)
$12.24 (257.14%)
Buy Since 02-Jun-2025
$22
$17.57 (396.61%)
$20
7 months 13 days ago
(09-Mar-2026)
0/3 (0%)
$16.84 (326.36%)
Which stock is Jason Mccarthy most bullish on?
Which stock is Jason Mccarthy most reserved on?
What Year was the first public recommendation made by Jason Mccarthy?
